studi
period
cat
clinic
sign
evalu
fulfil
clinic
inclus
criteria
enrol
cat
owner
consent
collect
biopsi
specimen
thu
symptomat
cat
fulli
investig
sever
exclud
studi
absenc
histopatholog
evid
enter
cholang
pancreat
combin
histopatholog
examin
period
cat
without
clinic
sign
diseas
also
fulli
investig
use
diagnost
procedur
use
symptomat
cat
biopsi
specimen
collect
schedul
ovariohysterectomi
cat
owner
given
written
consent
complet
histopatholog
examin
number
cat
exclud
studi
specif
criteria
histopatholog
examin
cat
inflammatori
lesion
detect
organ
examin
includ
studi
group
regardless
presenc
clinic
sign
therefor
studi
group
consist
cat
histopatholog
evid
inflamm
intestin
liver
pancrea
combin
without
clinic
sign
wherea
asymptomat
cat
normal
histopatholog
find
intestin
liver
pancrea
constitut
control
group
histori
signal
physic
examin
find
record
cat
examin
laboratori
analysi
day
laparotomi
cat
includ
fecal
parasitolog
examin
serum
biochemistri
profil
albumin
alb
blood
urea
nitrogen
bun
creatinin
crea
alkalin
phosphatas
activ
alp
alanin
amino
transferas
activ
alt
transferas
activ
aspart
transaminas
activ
ast
total
bilirubin
tbil
lipas
activ
lipa
calcium
ca
phosphoru
p
potassium
k
sodium
na
blood
coagul
profil
includ
prothrombin
time
pt
partial
thromboplastin
time
ptt
serum
total
thyroxin
free
thyroxin
serum
felin
pancreat
lipas
immunoreact
fpli
measur
spec
immunoreact
felin
test
diagnost
imag
includ
thorac
abdomin
abdomin
minimum
tissu
sampl
felin
liver
pancrea
duodenum
jejunum
ileum
collect
surgeri
cat
examin
data
intestin
biopsi
specimen
collect
ileal
biopsi
taken
cat
studi
group
cat
exclud
analysi
biopsi
sampl
embed
paraffin
cut
stain
hematoxylin
eosin
biopsi
sampl
evalu
blind
fashion
veterinari
pathologist
tp
diagnos
base
previous
describ
histopatholog
sever
score
ascend
scale
score
given
basi
inflammatori
cell
accumul
fibrosi
epitheli
lesion
accord
follow
scale
normal
mild
mild
moder
moder
sever
highest
among
separ
score
given
part
intestin
consid
enter
score
exampl
grade
system
cholang
pancreat
enter
shown
fig
cholang
score
correspond
bridg
lesion
assign
cat
examin
thu
illustr
fig
hepat
lipidosi
also
score
ascend
scale
base
extent
hepat
cell
lipidosi
liver
section
examin
normal
hepatocyt
affect
hepatocyt
affect
hepatocyt
affect
use
histopatholog
result
criterion
cat
studi
classifi
group
data
process
comparison
among
group
symptomat
asymptomat
cat
made
cat
pancreat
lesion
alon
ibd
lesion
combin
pancreat
exclud
analysi
small
sampl
size
continu
variabl
compar
appropri
wherea
use
comparison
proport
percentag
bonferroni
correct
signific
level
differ
among
median
valu
highlight
report
minimum
statist
signific
median
differ
observ
signific
level
p
mssdo
hypothesi
test
procedur
observ
signific
level
estim
appropri
either
exact
method
exact
method
simul
base
resampl
binomi
bootstrap
confid
interv
ci
comput
proport
correl
histopatholog
laboratori
variabl
examin
spearman
rho
coeffici
level
signific
set
p
statist
analys
perform
statist
softwar
symptomat
cat
examin
ci
diagnos
inflammatori
lesion
least
target
organ
includ
studi
wherea
cat
ci
diagnos
neoplasm
noninflammatori
condit
data
exclud
studi
symptomat
cat
studi
group
diagnos
cholang
cholang
alon
ci
pancreat
pancreat
alon
ci
ibd
ibd
alon
ci
concomit
inflamm
organ
ibd
either
cholang
pancreat
evid
ci
cat
inflamm
organ
triaditi
ci
cat
histopatholog
examin
asymptomat
cat
sampl
ovariohysterectomi
indic
presenc
inflammatori
lesion
liver
pancrea
intestin
combin
cat
ci
eleven
asymptomat
cat
remov
studi
accord
exclus
criteria
data
remain
asymptomat
cat
inflammatori
lesion
symptomat
cat
inflamm
constitut
studi
group
cat
analysi
wherea
remain
clinic
histopatholog
normal
cat
compris
control
group
asymptomat
cat
studi
group
lesion
cholang
alon
identifi
ci
cat
enter
alon
ci
combin
enter
cholang
enter
pancreat
identifi
ci
cat
neither
pancreat
alon
triaditi
alon
identifi
among
asymptomat
cat
use
histopatholog
evid
inflamm
criterion
symptomat
asymptomat
cat
studi
classifi
group
follow
control
ctrl
n
ibd
n
cholang
ch
n
pancreat
p
n
ibd
ch
ibdch
n
ibd
p
ibdp
n
ibd
ch
p
ibdchp
n
macroscop
cat
evid
enter
laparotomi
includ
mild
enlarg
mesenter
lymph
node
diffus
mildli
firm
intestin
wall
forti
cat
studi
group
ci
histolog
evid
inflamm
compat
ibd
ci
asymptomat
case
histolog
detect
lesion
ci
symptomat
case
case
ci
concurr
inflamm
bile
duct
pancrea
detect
cholang
ci
pancreat
ci
triaditi
ci
ibd
lesion
abnorm
infiltr
inflammatori
cell
present
lamina
propria
fig
inflammatori
cell
compon
primarili
consist
lymphocyt
plasma
cell
macrophag
neutrophil
also
present
variabl
number
case
occasion
eosinophil
also
observ
major
case
promin
increas
intraepitheli
lymphocyt
observ
wherea
small
percentag
case
intraepitheli
globul
leukocyt
also
evid
depend
predomin
type
inflammatori
cell
ibd
lesion
character
lymphocyt
plasmacyt
lymphoplasmacyt
architectur
lesion
ibd
describ
tabl
histopatholog
lesion
ibd
extend
part
duodenum
jejunum
ileum
small
intestin
examin
variabl
degre
sever
sever
enter
cat
either
symptomat
asymptomat
group
shown
tabl
signific
differ
ibd
score
symptomat
asymptomat
cat
p
histolog
sever
score
differ
subgroup
base
organ
affect
shown
tabl
signific
differ
histolog
sever
intestin
inflamm
among
subgroup
df
p
cat
gross
abnorm
albeit
mild
laparotomi
includ
subtli
mottl
hepat
surfac
pale
light
yellow
discolor
hepat
parenchyma
mild
enlarg
liver
evidenc
slightli
round
edg
histopatholog
evid
cholang
fig
note
ci
cat
studi
group
ci
symptomat
ci
asymptomat
group
ci
cholang
inflammatori
lesion
found
wherea
ci
cholang
coexist
either
lesion
ibd
ci
ibd
pancreat
ci
specif
lesion
identifi
includ
inflammatori
cell
aggreg
portal
area
fibrosi
hyperplasia
bile
duct
oval
cell
major
cat
ci
inflammatori
cell
compon
consist
primarili
lymphocyt
rel
small
number
plasma
cell
lymphocyt
cholang
regard
lymphocyt
type
cholang
coexist
observ
case
ci
either
combin
ibd
ci
combin
triaditi
ci
small
number
case
ci
addit
mononuclear
cell
consider
popul
neutrophil
present
chronic
neutrophil
cholang
major
chronic
neutrophil
cholang
case
also
ibd
lesion
triaditi
cholestasi
evid
ci
cat
cholang
small
number
cat
cholang
also
focal
multifoc
hepat
ci
variabl
size
focal
hepat
lesion
typic
mix
mononuclear
cell
neutrophil
infiltr
ci
without
necrosi
hepat
parenchyma
sever
score
cholang
lesion
symptomat
asymptomat
group
shown
tabl
comparison
sever
score
cholang
symptomat
asymptomat
cat
show
signific
differ
p
comparison
cholang
sever
score
among
subgroup
shown
tabl
statist
analysi
identifi
signific
differ
histolog
cholang
score
group
ch
ibdch
p
ch
ibdchp
p
ibdch
ibdchp
p
macroscop
cat
gross
lesion
pancrea
laparotomi
includ
edema
presenc
nodul
plaqu
firm
consist
hyperemia
necrosi
peripancreat
fat
necrosi
identifi
presenc
saponifi
fat
presenc
singl
pancreat
cyst
histopatholog
evid
pancreat
note
ci
cat
studi
group
ci
symptomat
ci
asymptomat
group
pancreat
lesion
alon
observ
cat
wherea
remain
cat
also
show
concurr
lesion
ibd
cat
ibd
cholang
cat
chronic
lesion
pancreat
character
mononuclear
cell
infiltr
interlobular
fibrosi
intralobular
fibrosi
seen
pancreata
evid
pancreat
fig
regard
type
pancreat
coexist
observ
case
either
combin
ibd
combin
triaditi
remain
cat
pancreat
inflammatori
cell
compon
includ
consider
number
neutrophil
apart
mononuclear
cell
fibrosi
case
pancreat
classifi
chronic
activ
remain
case
sever
acut
necrot
pancreat
present
concurr
chronic
pancreat
cat
extens
necrosi
pancreat
parenchyma
peripancreat
fat
observ
major
pancreat
case
neutrophil
cell
compon
also
ibd
lesion
triaditi
sever
pancreat
lesion
symptomat
asymptomat
cat
group
shown
tabl
comparison
sever
score
symptomat
asymptomat
cat
lesion
feasibl
cat
pancreat
asymptomat
howev
statist
comparison
symptomat
asymptomat
cat
consid
cat
without
pancreat
score
show
statist
signific
differ
symptomat
asymptomat
cat
p
score
pancreat
lesion
subgroup
base
organ
involv
present
tabl
microvesicular
macrovesicular
lipidosi
observ
ci
cat
studi
group
ci
symptomat
ci
asymptomat
cat
control
cat
specif
ibd
cat
ch
cat
ibdch
cat
ibdchp
cat
ibdp
cat
show
evid
hepat
lipidosi
regard
breed
distribut
within
group
cat
statist
analysi
identifi
statist
signific
differ
p
studi
design
major
cat
enrol
femal
preclud
analysi
sex
distribut
data
regard
age
cat
histopatholog
evid
cholang
pancreat
ibd
combin
significantli
older
compar
control
cat
median
age
year
comparison
p
cat
triaditi
median
age
year
significantli
older
cat
lesion
ibd
median
age
year
cholang
median
age
year
combin
ibd
cholang
median
age
year
comparison
p
median
age
cat
well
differ
among
cat
group
present
tabl
presenc
absenc
clinic
sign
subgroup
cat
present
tabl
comparison
proport
symptomat
vs
asymptomat
cat
group
seri
determin
cat
ibdchp
group
like
clinic
sign
compar
subgroup
df
p
tabl
common
clinic
sign
report
symptomat
cat
vomit
lethargi
anorexia
weight
loss
abnorm
fece
slightli
soft
fece
wateri
diarrhea
poor
bodi
condit
score
jaundic
polyphagia
physic
examin
abnorm
find
palpat
abdomen
eg
mass
effect
suspici
mesenter
lymph
node
enlarg
thicken
intestin
wall
mass
effect
palpat
anterior
abdomen
pain
hepatomegali
also
common
comparison
proport
cat
present
clinic
sign
subgroup
seri
determin
disrupt
appetit
df
p
vomit
df
p
present
statist
significantli
higher
proport
cat
ibdchp
group
compar
group
cat
triaditi
group
report
alter
appetit
present
polyphagia
along
poor
bodi
condit
score
decreas
appetit
also
cat
present
vomit
tabl
comparison
result
cbc
among
subgroup
indic
statist
signific
differ
hematocrit
number
circul
neutrophil
lymphocyt
blood
result
comparison
well
number
cat
subgroup
valu
outsid
refer
interv
shown
tabl
none
cat
studi
abnorm
platelet
count
common
serum
biochemistri
find
increas
activ
alt
alp
ast
increas
concentr
total
bilirubin
also
serum
pancreat
marker
ftli
fpli
increas
cat
statist
signific
differ
among
group
alt
ast
activ
p
alb
fpli
concentr
result
comparison
well
number
cat
group
valu
outsid
refer
interv
shown
tabl
addit
serum
fpli
result
cat
without
histopatholog
evid
pancreat
shown
tabl
diagnost
imag
find
normal
cat
control
group
mani
cat
studi
group
cat
studi
group
thorac
radiograph
taken
also
abdomin
radiograph
taken
abnorm
detect
thorac
radiograph
abdomin
radiograph
cat
normal
find
wherea
radiographi
disclos
hepatomegali
cat
abnorm
air
distribut
intestin
lumen
indic
enter
cat
cat
studi
group
underw
abdomin
ultrasound
examin
abnorm
remain
cat
ultrasonographi
abdomen
disclos
presenc
variou
abnorm
mesenter
lymph
node
enlarg
increas
echogen
felin
liver
bowel
dysmotil
indic
ileu
thicken
intestin
wall
hepatomegali
hepat
cyst
format
enlarg
hypoechogen
pancrea
decreas
echogen
pancrea
cyst
format
increas
echogen
anterior
abdomen
periton
effus
mild
posit
correl
observ
histopatholog
ibd
score
number
comorbid
addit
ibd
rho
p
n
cat
without
histopatholog
evid
ibd
exclud
correl
analysi
find
neg
correl
detect
score
ibd
lesion
result
pcv
rho
p
blood
lymphocyt
count
rho
p
concentr
alb
rho
p
mild
posit
correl
detect
histopatholog
cholang
score
blood
neutrophil
count
rho
p
fpli
rho
p
wherea
correl
concentr
alb
rho
p
neg
mild
posit
correl
detect
pancreat
score
age
rho
p
ptt
rho
p
alt
activ
rho
p
concentr
lipa
rho
p
fpli
rho
p
neg
correl
identifi
histopatholog
pancreat
score
pvc
rho
p
strong
posit
correl
observ
hepat
lipidosi
score
activ
alp
rho
p
ast
rho
p
rho
p
concentr
tbil
rho
p
mild
posit
correl
observ
alt
activ
rho
p
total
serum
lipas
activ
rho
p
knowledg
first
prospect
clinic
studi
investig
coexist
felin
inflammatori
liver
pancreat
small
bowel
diseas
clinic
case
studi
indic
histopatholog
lesion
enter
cholang
pancreat
combin
might
coexist
cat
present
complex
case
sever
inflammatori
diseas
histopatholog
evid
inflamm
organ
present
ci
symptomat
cat
triaditi
present
ci
case
combin
ibd
either
cholang
pancreat
ci
cat
furthermor
studi
identifi
evid
inflamm
high
proport
asymptomat
cat
histopatholog
lesion
either
cholang
enter
alon
combin
inflammatori
infiltr
organ
identifi
absenc
clinic
sign
ci
cat
combin
ibd
cholang
pancreat
case
present
ci
asymptomat
cat
find
suggest
ibd
combin
inflammatori
diseas
organ
begin
onset
clinic
sign
case
clinic
sign
mild
transient
miss
owner
furthermor
studi
pancreat
alon
triaditi
present
cat
symptomat
also
combin
cholang
pancreat
without
concurr
lesion
ibd
detect
addit
histolog
sever
ibd
lesion
posit
correl
number
comorbid
thu
result
suggest
sever
ibd
lesion
presenc
pancreat
play
critic
role
overt
clinic
diseas
triaditi
previous
mention
current
knowledg
relat
triaditi
cat
mainli
deriv
small
number
retrospect
studi
base
necropsi
find
differ
histopatholog
classif
compon
diseas
make
comparison
among
differ
studi
studi
cholangiohepat
cat
concurr
pancreat
ibd
lesion
report
cholangiohepat
similar
recent
studi
triaditi
identifi
case
concurr
presenc
pancreat
ibd
report
cat
variou
histolog
subtyp
inflammatori
liver
studi
triaditi
identifi
ci
cat
cholang
regard
type
cholang
triaditi
detect
ci
case
lymphocyt
cholang
cat
chronic
neutrophil
cholang
previou
studi
cat
either
euthan
die
enrol
like
indic
sever
diseas
patient
studi
histopatholog
evalu
biopsi
specimen
felin
liver
pancrea
small
intestin
perform
although
highli
local
inflamm
miss
techniqu
remain
gold
standard
diagnos
although
invas
open
surgeri
select
instead
method
laparotomi
allow
direct
visual
inspect
organ
detect
gross
lesion
also
facilit
control
hemorrhag
liver
biopsi
laparotomi
also
allow
collect
tissu
sampl
segment
small
intestin
facilit
differenti
ibd
studi
lymphocyt
plasma
cell
predomin
cell
type
seen
site
evalu
cat
chronic
inflammatori
liver
diseas
mostli
affect
biliari
tree
portal
area
less
commonli
hepat
also
cholang
predominantli
accord
recent
studi
mani
case
lymphocyt
cholang
remain
subclin
wherea
concurr
inflammatori
diseas
pancreat
ibd
frequent
might
associ
clinic
regard
pancreat
inflamm
cat
chronic
pancreat
like
concurr
final
lymphoplasmocyt
enter
consid
common
type
ibd
studi
statist
signific
differ
sever
histopatholog
lesion
either
singl
organ
combin
sever
organ
identifi
symptomat
asymptomat
cat
howev
epitheli
dysplasia
seen
asymptomat
cat
lesion
suggest
ibd
also
sever
cholang
lesion
present
alon
differ
significantli
present
along
ibd
ibd
pancreat
lesion
contrast
histopatholog
lesion
ibd
cat
triaditi
significantli
sever
cat
ibd
lesion
present
alon
find
support
hypothesi
multifactori
syndrom
ibd
might
play
predomin
role
regard
age
predisposit
compon
diseas
triaditi
lymphocyt
cholang
describ
affect
mostli
older
wherea
investig
also
report
diseas
young
although
pancreat
potenti
affect
cat
age
lymphocyt
pancreat
report
occur
commonli
older
inflammatori
bowel
diseas
report
common
year
old
older
year
old
howev
diseas
might
occur
age
includ
cat
year
studi
indic
cat
inflammatori
lesion
significantli
older
compar
control
median
age
year
observ
might
caus
fact
control
cat
select
cat
present
ovariohysterectomi
furthermor
shown
sever
pancreat
posit
relat
age
cat
triaditi
median
age
year
significantli
older
cat
lesion
cholang
ibd
ibd
combin
cholang
median
age
year
although
statist
signific
correl
age
number
comorbid
ibd
could
confirm
increas
frequenc
older
cat
among
cat
triaditi
note
compar
cat
comorbid
ibd
regard
clinic
present
cat
combin
inflammatori
lesion
sever
organ
variou
nonspecif
clinic
sign
common
diseas
compon
report
owner
incid
increas
cat
triaditi
alter
appetit
either
increas
decreas
vomit
predomin
clinic
sign
hematolog
serum
biochem
find
cat
enrol
studi
expect
diseas
depend
sever
inflammatori
lesion
ibd
associ
decreas
pcv
peripher
lymphocyt
count
serum
albumin
concentr
cholang
associ
decreas
alb
increas
number
blood
neutrophil
well
increas
serum
fpli
furthermor
pancreat
associ
increas
ptt
alt
activ
total
lipas
activ
fpli
decreas
pcv
shown
data
hepat
lipidosi
often
associ
cholang
pancreat
combin
found
ci
cat
studi
presenc
hepat
lipidosi
affect
hepat
function
consequ
clinic
laboratori
variabl
diseas
studi
sever
lipidosi
strongli
associ
increas
serum
activ
alp
ast
increas
concentr
tbil
mildli
associ
increas
serum
activ
alt
serum
total
lipas
activ
minim
invas
reliabl
specif
test
diagnosi
pancreat
greatli
need
although
histopatholog
examin
pancreat
biopsi
specimen
allow
definit
diagnosi
inflammatori
infiltr
observ
pancreat
biopsi
alway
feasibl
furthermor
focal
inflammatori
lesion
pancreat
might
escap
serum
total
lipas
serum
consid
sensit
specif
diagnosi
exocrin
pancreat
diseas
cat
confirm
studi
ftli
test
concern
serum
total
lipas
activ
although
mild
posit
correl
detect
median
activ
test
sever
score
pancreat
differ
control
triaditi
group
statist
signific
felin
pancreat
lipas
immunoreact
fpli
measur
spec
assay
specif
quantifi
lipas
origin
pancreat
acinar
fpli
overal
sensit
diagnosi
pancreat
estim
rang
mild
case
case
pancreat
specif
reach
healthi
cat
cat
gastrointestin
diseas
without
histopatholog
lesion
recent
studi
natur
occur
pancreat
sensit
method
report
shown
studi
median
fpli
cat
triaditi
significantli
higher
compar
control
group
although
median
score
pancreat
record
triaditi
group
suggest
pancreat
median
fpli
exceed
upper
limit
refer
interv
moreov
statist
signific
increas
median
valu
variabl
also
observ
group
ch
compar
control
group
cat
one
possibl
explan
number
cat
group
ch
might
local
pancreat
miss
histopatholog
singl
biopsi
specimen
evalu
purpos
studi
consequ
addit
studi
involv
larger
number
cat
triaditi
variabl
sever
pancreat
need
sever
pancreat
biopsi
specimen
collect
evalu
serum
fpli
must
consid
along
clinic
laboratori
find
maxim
diagnost
capabl
pancreat
triaditi
liver
pancrea
intestin
close
associ
anatom
function
gut
liver
play
import
role
immunolog
complex
ecosystem
intestin
microbiota
influenc
numer
function
overal
health
disrupt
interact
local
immun
system
lead
gastrointestin
current
studi
rais
possibl
enter
bacteria
relat
cholang
overal
autoimmun
process
might
underli
caus
triaditi
studi
limit
deserv
mention
examin
rel
small
popul
symptomat
cat
might
limit
power
studi
detect
differ
among
group
tissu
specimen
per
site
collect
cat
inher
risk
biopsi
especi
critic
ill
cat
might
limit
accuraci
histopatholog
assess
addit
pathologist
examin
histolog
section
howev
avoid
problem
suboptim
interobserv
agreement
conclus
prospect
studi
evalu
preval
coexist
ibd
cholang
pancreat
symptomat
asymptomat
cat
statist
signific
differ
sever
histopatholog
lesion
either
singl
organ
combin
sever
organ
identifi
symptomat
asymptomat
cat
histopatholog
lesion
ibd
cat
triaditi
significantli
sever
cat
ibd
lesion
present
alon
suggest
ibd
might
play
role
develop
triaditi
research
essenti
better
understand
complex
interact
among
inflamm
organ
thu
improv
diagnost
therapeut
capabl
